glp-1 constipation management Why Matters While on GLP-1/GIP-1 Medications Constipation is a common and sometimes underappreciated side effect of and GIP-1 agonists like semaglutide (Wegovy®) or tirzepatide (Zepbound®). Left untreated, it can lead Made with a blend of science GLP-1 Meds Slowed Your Digestion?

Insulin degludec and liraglutide (Xultophy) injection [package insert]

Chronic Conditions: Risks for kidney disease, infections, and clotting disorders also fell significantly

This builds on his work to understand 'how circulating GLP-1 can produce multiple actions, both directly and indirectly, on multiple organs' which he has pursued for many years with colleagues (McLean, Wong, Campbell)

Primary Research Extensive primary research was conducted after acquiring basic knowledge about the global GLP-1 agonists market scenario through secondary research

Bioavailability and why it matters for frequency Injectable semaglutide achieves approximately 89% bioavailability

DOI: 10.1038/s41366-026-02088-1,